Analysis of serum cardiac biomarkers and treadmill exercise test-electrocardiogram for the diagnosis of coronary heart disease in suspected patients

Acta Biochimica et Biophysica Sinica

Volumn 42, Issue 1, 2010, Pages 39-44

  Zhu, Zhenhua ^a   Yan, Yan ^a   Wang, Qibing ^a   Qian, Juying ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Coronary angiography; Coronary heart disease; Myocardial ischemia; N terminal pro B type natriuretic peptide (NT proBNP); Non invasive examination; Serum biomarker

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT;

ARTICLE; BLOOD; CHEMISTRY; CORONARY ARTERY DISEASE; EXERCISE TEST; HUMAN;

BIOLOGICAL MARKERS; BLOOD; CORONARY DISEASE; EXERCISE TEST; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 73549087205     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmp103     Document Type: Article

References (10)

1. Kost GJ and Tran NK. Point-of-care testing and cardiac biomarkers: the standard of care and vision for chest pain centers. Cardiol Clin 2005, 23: 467-490.
2. Pope JH, Aufderheide TP, Ruthazer R and Woolard RH. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000, 342: 1163-1170.
3. The Task Force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Guidelines for the diagnosis and treatment of non-STsegment elevation acute coronary syndromes. Eur Heart J 2007, 28: 1598-1660.
4. Bar-Or D, Lau E, Rao N, Bampos N, Winkler JV and Curtis CG. Reduction in cobalt binding capacity of human albumin with myocardial ischemia. Ann Emerg Med 1999, 34: S56.
5. Bar-Or D, Curtis G, Rao N, Bampos N and Lau E. Characterization of the Co2+ and Ni2+ binding amino-acid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 2001, 268: 42-47.
6. Bar-Or D, Lau E and Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia: a preliminary report. Emerg Med 2000, 19: 311-315.
7. Omland T, Aakvaag A and Vik-Mo H. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. Heart 1996, 76: 232-237.
8. Eui-Young C, Hyuck MK and Yong-Won Y. Assessment of extent of myocardial ischemia in patients with non-ST elevation acute coronary syndrome using serum B-type natriuretic peptide level. Yonsei Med J 2004, 45: 255-262.
9. Sadanandan S, Cannon CP and Chekuri K. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non- ST segment elevation myocardial infarction. J Am Coll Cardiol 2004, 44: 564-568.
10. Bassan R, Potsch A and Maisel A. B-type natriuretic peptide: a novel early blood marker of myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005, 26: 234-240.